Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Radiol Oncol. 2020 May 28;54(4):488-494. doi: 10.2478/raon-2020-0030.
Background The aim of our study was to evaluate the quality of surgery of Slovenian breast cancer screening program (DORA) using the requested EU standards. Furthermore, we investigated whether regular quality control over the 3-year period improved the quality of surgical management. Patients and methods Patients who required surgical management within DORA between January 1st, 2016 and December 31st, 2018 were included in the retrospective study. Quality indicators (QIs) were adjusted mainly according to European Society of Breast Cancer Specialists (EUSOMA) and European Breast Cancer Network (EBCN) recommendations. Five QIs for therapeutic and two for diagnostic surgeries were selected. Additionally, variability in achieving the requested QIs among surgeons was analysed. Results Between 2016 and 2018, 14 surgeons performed 1421 breast procedures in 1398 women. There were 1197 therapeutical (for proven breast cancer) and 224 diagnostic surgical interventions respectively. Overall, the minimal standard was met in two QIs for therapeutic and none for diagnostic procedures. A statistically significant improvement in three QIs for therapeutic and in one QI for diagnostic procedures was observed however, indicating that regular quality control improves the quality of surgery. A high variability in achieving the requested QIs was observed among surgeons, which remained high throughout the study period. Conclusions Adherence to all selected surgical QIs in patients from screening program is difficult to achieve, especially to those specifically defined for screen-detected lesions. Regular quality control may improve results over time. Reducing the number of surgeons dedicated to breast pathology may reduce variability of management inside the institution.
我们的研究旨在使用欧盟要求的标准评估斯洛文尼亚乳腺癌筛查计划(DORA)的手术质量。此外,我们还调查了在 3 年期间定期进行质量控制是否可以改善手术管理的质量。
我们对 2016 年 1 月 1 日至 2018 年 12 月 31 日期间在 DORA 中需要手术治疗的患者进行了回顾性研究。质量指标(QIs)主要根据欧洲乳腺肿瘤专家学会(EUSOMA)和欧洲乳腺癌网络(EBCN)的建议进行调整。选择了 5 个治疗性 QI 和 2 个诊断性 QI。此外,还分析了外科医生在实现所需 QI 方面的差异。
2016 年至 2018 年间,14 名外科医生为 1398 名女性的 1421 例乳房手术提供服务。其中分别有 1197 例为治疗性(确诊为乳腺癌)和 224 例诊断性手术。总体而言,在治疗性 QI 中有两项达到最低标准,而诊断性 QI 则没有一项达到。然而,在治疗性 QI 中有三项和诊断性 QI 中有一项观察到统计学上的显著改善,表明定期质量控制可改善手术质量。尽管在整个研究期间,外科医生在实现所需 QI 方面存在高度的变异性,但仍观察到这种变异性有所提高。
在筛查计划中,很难达到所有筛选出的患者的所有选定手术 QI,尤其是那些专门针对筛查发现的病变定义的 QI。定期的质量控制可能会随着时间的推移而提高结果。减少专门从事乳腺病理学的外科医生数量可能会降低机构内管理的变异性。